Research Paper Volume 16, Issue 1 pp 493—517
Predicting prognosis and immune status in sarcomas by identifying necroptosis-related lncRNAs
Figure 4. Verification of the risk model. (A) Survival curves of patients in the GEO cohort. (B) ROC curves in the GEO cohort. (C) The triple risk plot in the GEO cohort (* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; ns, no significance). (D) Survival curves of patients in the ICGC and TARGET cohorts. (E) ROC curves in the ICGC and TARGET cohorts. (F) The triple risk plot in the ICGC and TARGET cohorts (* P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; ns, no significance).